Neuroendocrine regulation of cancer progression: II. Immunological mechanisms, clinical relevance, and prophylactic measures

Psychoneuroimmunology, Two-Volume Set

Volumn 1, Issue , 2007, Pages 251-265

  Avraham, Roi ^a   Ben Eliyahu, Shamgar ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46049091306     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012088576-3/50016-2     Document Type: Chapter

References (115)

1. Abitri N., Greenfeld K., Atzil S., Melamed R., Rosenne E., Avraham R., Ben-Eliyahu S. A new frontier for antianxiety drugs?. Israel Bio-Psychology Annual Meeting 2005.
2. Atzil S., Arad M., Abiri N., Rosenne E., Beilin B., Ben-Eliyahu S. Blood transfusion suppresses host resistance to experimental tumor metastasis: Effects of histocompatibility and storage time. Annual Meeting of the Psychoneuroimmunology Research Society 2004.
3. Avraham R., Rosenne E., Melamed R., Ben-Eliyahu S. Combining immunotherapy with PNI-based interventions: a win-win approach in the post operative setting. Psychoneuroimmunology Research Society 2005.
4. Avraham R., Schwartz Y., Rosenne E., Melamed R., Ben-Eliyahu S. IL-12-based immunotherapy reduces postsurgery immunosuppression and metastasis, and increases survival from experimental leukemia. Psychoneuroimmunology Research Society 2004, Elsevier, Titisee, Germany.
5. Barlozzari T., Leonhardt J., Wiltrout R.H., Herberman R.B., Reynolds C.W. Direct evidence for the role of LGL in the inhibition of experimental tumor metastases. Journal of Immunology 1985, 134(4):2783-2789.
6. Barlozzari T., Reynolds C.W., Herberman R.B. In vivo role of natural killer cells: involvement of large granular lymphocytes in the clearance of tumor cells in anti-asialo GM1-treated rats. Journal of Immunology 1983, 131(2):1024-1027.
7. Barrett W.L., First M.R., Aron B.S., Penn I. Clinical course of malignancies in renal transplant recipients. Cancer 1993, 72(7):2186-2189.
8. Bar-Yosef S., Melamed R., Page A.G., Shakhar G., Shakhar K., Ben-Eliyahu S. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001, 94(6):1066-1073.
9. Ben-Eliyahu S., Page G.G. In vivo assessment of natural killer cell activity in rats. Progress in Neuroendocrineimmunology 1992, 5:199-214.
10. Ben-Eliyahu S., Page G.G., Yirmiya R., Shakhar G. Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. Int. J. Cancer 1999, 80(6):880-888.
11. Ben-Eliyahu S., Page G.G., Yirmiya R., Taylor A.N. Acute alcohol intoxication suppresses natural killer cell activity and promotes tumor metastasis. Nature Medicine 1996, 2(4):457-460.
12. Ben-Eliyahu S., Shakhar G., Page A.G., Stefanski V, Shakhar K. Suppression of NK cell activity and of resistance to metastasis by stress: a role for adrenal catecholamines and betaadrenoceptors. Neuroimmunomodulation 2000, 8(3):154-164.
13. Ben-Eliyahu S., Shakhar G., Rosenne E., Levinson Y., Beilin B. Hypothermia in barbiturate-anesthetized rats suppresses natural killer cell activity and compromises resistance to tumor metastasis: a role for adrenergic mec. Anesthesiology 1999, 91(3):732-740.
14. Ben-Eliyahu S., Yirmiya R., Liebeskind J.C., Taylor A.N., Gale R.P. Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain, Behavior, and Immunity 1991, 5(2):193-205.
15. Brittenden J. Natural killer cells and cancer. Cancer 1996, 77(7):1226-1243.
16. Brutkiewicz A.R., Sriram V. Natural killer T (NKT) cells and their role in antitumor immunity. Crit. Rev. Oncol. Hematol. 2002, 41(3):287-298.
17. Carter J.J. The immunologic consequences of laparoscopy in oncology. Surgical Oncology Clinics of North America 2001, 10(3):655-677.
18. Cech A.C., Shou J., Gallagher H., Daly J.M. Glucocorticoid receptor blockade reverses postinjury macrophage suppression. Arch. Surg. 1994, 129(12):1227-1232.
19. Chambrier C., Chassard D., Bienvenu J., Saudin F., Paturel B., Garrigue C., Barbier Y., Bouletreau P. Cytokine and hormonal changes after cholecystectomy. Effect of ibuprofen pretreatment. Ann. Surg. 1996, 224(2):178-182.
20. Cohen S., Herbert T.B. Health psychology: psychological factors and physical disease from the perspective of human psychoneuroimmunology. Annual Review of Psychology 1996, 47:113-142.
21. Colacchio T.A., Yeager M.P., Hildebrandt L.W. Perioperative immunomodulation in cancer surgery. Am. J. Surg. 1994, 167(1):174-179.
22. Cole S.W., Korin Y.D., Fahey J.L., Zack J.A. Norepinephrine accelerates HIV replication via protein kinase Adependent effects on cytokine production. J. Immunol. 1998, 161(2):610-616.
23. Cole S.W., Naliboff B.D., Kemeny M.E., Griswold M.P., Fahey J.L., Zack J.A. Impaired response to HAART in HIV-infected individuals with high autonomic nervous system activity. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(22):12695-12700.
24. Coley W.B. The treatment of malignant tumors by repeated inoculations of erysipelas. With a report of ten original cases. A, J. Med. Sci. 1893, 105:487-511. 1893.
25. Collingridge D.R., Hill S.A., Chaplin D.J. Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxia. Br. J. Cancer 2001, 84(5):626-630.
26. Da Costa M.L., Redmond P., Bouchier-Hayes D.J. The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery 1998, 124(3):516-525.
27. Deguchi M., Isobe Y., Matsukawa S., Yamaguchi A., Nakagawara G. Usefulness of metyrapone treatment to suppress cancer metastasis facilitated by surgical stress. Surgery 1998, 123(4):440-449.
28. Detry O., Honore P., Meurisse M., Jacquet N. Cancer in transplant recipients. Transplant Proc. 2000, 32(1):127.
29. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol. Rev. 2000, 52(4):595-638.
30. Eschwege P., Dumas F., Blanchet P., Le Maire V., Benoit G., Jardin A., Lacour B., Loric S. Haematogenous dissemination of prostatic epithelial cells during radical prostatectomy. Lancet 1995, 346(8989):1528-1530.
31. Faist E., Ertel W., Cohnert T., Huber P., Inthorn D., Heberer G. Immunoprotective effects of cyclooxygenase inhibition in patients with major surgical trauma. J. Trauma 1990, 30(1):8-17.
32. Faist E., Schinkel C., Zimmer S. Update on the mechanisms of immune suppression of injury and immune modulation. World J. Surg 1996, 20(4):454-459.
33. Fielding L.P., Wells B.W. Survival after primary and after staged resection for large bowel obstruction caused by cancer. Br. J. Surg. 1974, 61(1):16-18.
34. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J. Natl. Cancer Inst. 1990, 82(1):4-6.
35. Fong L., Engleman E.G. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 2000, 18:245-273.
36. Freire-Garabal M., Nunez M.J., Balboa J.L., Fernandez-Rial J.C., Vallejo L.G., Gonzalez-Bahillo J., Rey-Mendez M. Effects of alprazolam on cellular immune response to surgical stress in mice. Cancer Lett. 1993, 73(2-3):155-160.
37. Freire-Garabal M., Nunez M.J., Balboa J.L., Gonzalez-Bahillo J., Belmonte A. Effects of midazolam on the activity of phagocytosis in mice submitted to surgical stress. Pharmacol. Biochem. Behav. 1993, 46(3):605-608.
38. Fuchs E.J., Matzinger P. Is cancer dangerous to the immune system?. Semin. Immunol 1996, 8(5):271-280.
39. Galley H.F., DiMatteo M.A., Webster N.R. Immunomodulation by anaesthetic, sedative and analgesic agents: does it matter?. Intensive Care Med. 2000, 26(3):267-274.
40. Gilboa E., Nair S.K., Lyerly H.K. Immunotherapy of cancer with dendritic-cell-based vaccines. Cancer Immunol. Immunother 1998, 46(2):82-87.
41. Hewitt H.B. Second point: animal tumor models and their relevance to human tumor immunology. J. Biol. Response Mod. 1983, 2(3):210-216.
42. Inbar S., Rosenne E., Schwartz Y., Melamed R., Ben-Eliyahu S. The impact of stress hormones on progression of CRNK- 16 leukemia in rats, and the potential immunostressful nature of having leukemia. Brain, Behavior, and Immunity 2003, 17(3):182.
43. Ishihara Y., Matsunaga K., Iijima H., Fujii T., Oguchi Y., Kagawa J. Time-dependent effects of stressor application on metastasis of tumor cells in the lung and its regulation by an immunomodulator in mice. Psychoneuroendocrinology 1999, 24(7):713-726.
44. Kaseda S., Aoki T., Hangai N., Shimizu K. Better pulmonary function and prognosis with video-assisted thoracic surgery than with thoracotomy. Ann. Thorac. Surg. 2000, 70(5):1644-1646.
45. Khavari P. Cytotoxic cellular mediators of the immune response to neoplasia: a review. Yale Journal of Biology and Medicine 1987, 60(5):409-419.
46. Kikkawa H., Imafuku H., Tsukada H., Oku N. Possible role of immune surveillance at the initial phase of metastasis produced by B16BL6 melanoma cells. FEBS Lett. 2000, 467(2-3):211-216.
47. Killion J.J., Radinsky R., Fidler I.J. Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev. 1998, 17(3):279-284.
48. Klein H.G. Immunomodulatory aspects of transfusion: a once and future risk?. Anesthesiology 1999, 91(3):861-865.
49. Lai O.F., Chow P.K., Tan S., Song I.C., Soo K.C., Aw S.E., Yu W.K., Fook-Chong S.M., Satchithanantham S., Chan S.T. Changes in prostaglandin and nitric oxide levels in the hyperdynamic circulation following liver resection. J. Gastroenterol. Hepatol. 2000, 15(8):895-901.
50. Lang K., Drell T.L T., Lindecke A., Niggemann B., Kaltschmidt C., Zaenker K.S., Entschladen F. Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int. J. Cancer 2004, 112(2):231-238.
51. Le Cras A.E., Galley H.F., Webster N.R. Spinal but not general anesthesia increases the ratio of T helper 1 to T helper 2 cell subsets in patients undergoing transurethral resection of the prostate. Anesth. Analg. 1998, 87(6):1421-1425.
52. Lennard T.W., Shenton B.K., Borzotta A., Donnelly P.K., White M., Gerrie L.M., Proud G., Taylor R.M. The influence of surgical operations on components of the human immune system. Br. J. Surg. 1985, 72(10):771-776.
53. Lewis C., Murdoch C. Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies. Am. J. Pathol. 2005, 167(3):627-635.
54. Lin E., Calvano S.E., Lowry S.F. Inflammatory cytokines and cell response in surgery. Surgery 2000, 127(2):117-126.
55. Lindauer M., Stanislawski T., Haussler A., Antunes E., Cellary A., Huber C., Theobald M. The molecular basis of cancer immunotherapy by cytotoxic T lymphocytes. J. Mol. Med. 1998, 76(1):32-47.
56. Long E.O. Tumor cell recognition by natural killer cells. Semin. Cancer Biol. 2002, 12(1):57-61.
57. Lutgendorf S.K., Cole S., Costanzo E., Bradley S., Coffin J., Jabbari S., Rainwater K., Ritchie J.M., Yang M., Sood A.K. Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines. Clin. Cancer Res. 2003, 9(12):4514-4521.
58. Lutgendorf S.K., Costanzo E.S. Psychoneuroimmunology and health psychology: an integrative model. Brain Behav. Immun. 2003, 17(4):225-232.
59. Markewitz A., Faist E., Lang S., Hultner L., Weinhold C., Reichart B. An imbalance in T-helper cell subsets alters immune response after cardiac surgery. Eur. J. Cardiothorac. Surg. 1996, 10(1):61-67.
60. Mastorakos G., Chrousos G.P., Weber J.S. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J. Clin. Endocrinol. Metab. 1993, 77(6):1690-1694.
61. McCoy J.L., Rucker R., Petros J.A. Cell-mediated immunity to tumor-associated antigens is a better predictor of survival in early stage breast cancer than stage, grade or lymph node status. Breast Cancer Res. Treat. 2000, 60(3):227-234.
62. Melamed R., Bar-Yosef S., Shakhar G., Shakhar K., BenEliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanism prophylactic measures. Anesth. Analg. 2003, 97(5):1331-1339.
63. Melamed R., Rosenne E., Shakhar K., Schwartz Y., Abudarham N., Ben-Eliyahu S. Marginating pulmonary-NK activity and resistance to experimental tumor metastasis: suppression by surgery and the prophylactic use of a betaadrenergic antagon prostaglandin synthesis inhibitor. Brain Behav. Immun 2005, 19(2):114-126.
64. Moynihan J.A., Ader R. Psychoneuroimmunology: animal models of disease. Psychsomatic Medicine 1996, 58(6):546-558.
65. Munford R.S., Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am. J. Respir. Crit. Care Med. 2001, 163(2):316-321.
66. Nelson C.J., Lysle D.T. Severity, time, and betaadrenergic receptor involvement in surgery-induced immune alterations. J. Surg. Res. 1998, 80(2):115-122.
67. O'Reilly M.S., Boehm T., Shing Y., Fukai N., Vasios G., Lane W.S., Flynn E., Birkhead J.R., Olsen B.R., Folkman J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997, 88(2):277-285.
68. O'Reilly M.S., Holmgren L., Shing Y., Chen C., Rosenthal R.A., Moses M., Lane W.S., Cao Y., Sage E.H., Folkman J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994, 79(2):315-328.
69. Page G.G., Ben-Eliyahu S. COX-2 involvement in the tumor-enhancing effects of surgery. Brain, Behavior, and Immunity 2003, 17:194.
70. Page G.G., Blakely W.P., Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain 2001, 90(1-2):191-199.
71. Page G.G., McDonald J.S., Ben-Eliyahu S. Preoperative versus postoperative administration of morphine: impact on the neuroendocrine, behavioural, and metastaticenhancing effects of surgery. Br. J. Anaesth. 1998, 81(2):216-223.
72. Park P.G., Merryman J., Orloff M., Schuller H.M. Beta-adrenergic mitogenic signal transduction in peripheral lung adenocarcinoma: implications for individuals with preexisting chronic lung disease. Cancer Res. 1995, 55(16):3504-3508.
73. Pawelec G. Tumour escape: antitumour effectors too much of a good thing?. Cancer Immunol. Immunother. 2004, 53(3):262-274.
74. Penn I. The effect of immunosuppression on pre-existing cancers. Transplantation 1993, 55(4):742-747.
75. Platzer C., Docke W., Volk H., Prosch S. Catecholamines trigger IL-10 release in acute systemic stress reaction by direct stimulation of its promoter/enhancer activity in monocytic cells. J. Neuroimmunol. 2000, 105(1):31-38.
76. Pruett S.B., Fan R., Zheng Q. Acute ethanol administration profoundly alters poly I:C-induced cytokine expression in mice by a mechanism that is not dependent on corticosterone. Life Sci. 2003, 72(16):1825-1839.
77. Rameshwar P. Substance P: a regulatory neuropeptide for hematopoiesis and immune functions. Clin. Immunol. Immunopathol 1997, 85(2):129-133.
78. Romano M., Claria J. Cyclooxygenase-2 and 5- lipoxygenase converging functions on cell proliferation and tumor angiogenesis: implications for cancer therapy. FASEB J. 2003, 17(14):1986-1995.
79. Romero L.M., Raley-Susman K.M., Redish D.M., Brooke S.M., Horner H.C., Sapolsky R.M. Possible mechanism by which stress accelerates growth of virally derived tumors. Proc. Natl. Acad. Sci. U.S.A. 1992, 89(22):11084-11087.
80. Rosenberg S.A. Progress in human tumour immunology and immunotherapy. Nature 2001, 411(6835):380-384.
81. Sacerdote P., Bianchi M., Gaspani L., Manfredi B., Maucione A., Terno G., Ammatuna M., Panerai A.E. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth. Analg. 2000, 90(6):1411-1414.
82. Saurer T.B., Carrigan K.A., Ijames S.G., Lysle D.T. Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT. J. Neuroimmunol. 2004, 148(1-2):54-62.
83. Schaffer M., Beiter T., Becker H.D., Hunt T.K. Neuropeptides: mediators of inflammation and tissue repair?. Arch. Surg. 1998, 133(10):1107-1116.
84. Schirrmacher V. Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv. Cancer Res. 1985, 43:1-73.
85. Schlagenhauff B., Ellwanger U., Breuninger H., Stroebel W., Rassner G., Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res. 2000, 10(2):165-169.
86. Shakhar G., Abudarham N., Melamed R., Schwartz Y., Rosenne E., Ben-Eliyahu S. Protecting pulmonary NK activity from suppression by surgery: an approach to reduce postoperative metastasis. Annual Meeting of the Psychoneuro-immunology Research Society 2003.
87. Shakhar G., Ben-Eliyahu S. In vivo beta-adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. Journal of Immunology 1998, 160(7):3251-3258.
88. Shakhar G., Ben-Eliyahu S. Potential prophylactic measures against postoperative immunosuppression: could they reduce recurrence rates in oncological patients?. Ann. Surg. Oncol 2003, 10(8):972-992.
89. Shavit Y., Beilin B., Zaidel A., Smirnov G., Bessler H. Effects of preemptive analgesia on immune response in the postoperative period (abstract). Brain Behav. Immun. 2001, 15(2):127.
90. Shavit Y., Ben-Eliyahu S., Zeidel A., Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation 2004, 11(4):255-260.
91. Sheridan J.F., Dobbs C., Brown D., Zwilling B. Psychoneuroimmunology: stress effects on pathogenesis and immunity during infection. Clinical Microbiology Reviews 1994, 7(2):200-212.
92. Sietses C. Immunological consequences of laparoscopic surgery, speculations on the cause and clinical implications. Langenbecks Archives of Surgery 1999, 384(3):250-258.
93. Smyth M.J., Crowe N.Y., Hayakawa Y., Takeda K., Yagita H., Godfre D.I. NKT cells-conductors of tumor immunity?. Curr. Opin. Immunol. 2002, 14(2):165-171.
94. Smyth M.J., Godfrey D.I., Trapani J.A. A fresh look at tumor immunosurveillance and immunotherapy. Nat. Immunol. 2001, 2(4):293-299.
95. Soloski M.J. Recognition of tumor cells by the innate immune system. Curr. Opin. Immunol. 2001, 13(2):154-162.
96. Stefanski V., Ben-Eliyahu S. Social confrontation and tumor metastasis in rats: defeat and beta-adrenergic mechanisms. Physiol. Behav. 1996, 60(1):277-282.
97. Stefanski V., Engler H. Effects of acute and chronic social stress on blood cellular immunity in rats. Physiol. Behav. 1998, 64(5):733-741.
98. Sugi K., Kaneda Y., Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J. Surg. 2000, 24(1):27-30.
99. Sugi K., Kaneda Y., Esato K. Video-assisted thoracoscopic lobectomy achieves a satisfactory long-term prognosis in patients with clinical stage IA lung cancer. World J. Surg. 2000, 24(1):30-31. discussion.
100. Targarona E.M., Balague C., Knook M.M., Trias M. Laparoscopic surgery and surgical infection. Br. J. Surg. 2000, 87(5):536-544.
101. Tashiro T., Yamamori H., Takagi K., Morishima Y., Nakajima N. Effect of severity of stress on whole-body protein kinetics in surgical patients receiving parenteral nutrition. Nutrition 1996, 12(11-12):763-765.
102. Toes R.E., Ossendorp F., Offringa R., Melief C.J. CD4 T cells and their role in antitumor immune responses. J. Exp. Med. 1999, 189(5):753-756.
103. Torgersen K.M., Vaage J.T., Levy F.O., Hansson V., Rolstad B., Tasken K. Selective activation of cAMP-dependent protein kinase type I inhibits rat natural killer cell cytotoxicity. J. Biol. Chem. 1997, 272(9):5495-5500.
104. Turnbull A.V., Rivier C.L. Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: actions and mechanisms of action. Physiol. Rev. 1999, 79(1):1-71.
105. Uchida A., Kariya Y., Okamoto N., Sugie K., Fujimoto T., Yagita M. Prediction of postoperative clinical course by autologous tumor-killing activity in lung cancer patients. J. Natl. Cancer Inst. 1990, 82(21):1697-1701.
106. Vamvakas E.C., Blajchman M.A. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?. Blood 2001, 97(5):1180-1195.
107. Vitoratos N., Hassiakos D., Louridas C., Limuris G., Zourlas P.A. Prostaglandin F1a and prostaglandin E2 plasma levels after transvaginal cervical cerclage. Clin. Exp. Obstet. Gynecol. 1996, 23(1):21-25.
108. Wang D., Dubois R.N. Cyclooxygenase-2: a potential target in breast cancer. Semin. Oncol. 2004, 31(Suppl 3):64-73. 1.
109. Ward J.M., Reynolds C.W. Large granular lymphocyte leukemia. A heterogeneous lymphocytic leukemia in F344 rats. American Journal of Pathology 1983, 111(1):1-10.
110. Whalen M.M., Bankhurst A.D. Effects of betaadrenergic receptor activation, cholera toxin and forskolin on human natural killer cell function. Biochemical Journal 1990, 272(2):327-331.
111. Woiciechowsky C., Asadullah K., Nestler D., Eberhardt B., Platzer C., Schoning B., Glockner F., Lanksch W.R., Volk H.D., Docke W.D. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat. Med. 1998, 4(7):808-813.
112. Woiciechowsky C., Schoning B., Lanksch W.R., Volk H.D., Docke W.D. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J. Mol. Med. 1999, 77(11):769-780.
113. Yakar I., Melamed R., Shakhar G., Shakhar K., Rosenne E., Abudarham N., Page G.G., Ben-Eliyahu S. Prostaglandin e(2) suppresses NK activity in vivo and promotes postoperative tumor metastasis in rats. Ann. Surg. Oncol 2003, 10(4):469-479.
114. Yamaguchi K., Takagi Y., Aoki S., Futamura M., Saji S. Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection. Ann. Surg. 2000, 232(1):58-65.
115. Yirmiya R., Pollak Y., Morag M., Reichenberg A., Barak O., Avitsur R., Shavit Y., Ovadia H., Weidenfeld J., Morag A., Newman M.E., Pollmacher T. Illness, cytokines, and depression. Ann. N. Y. Acad. Sci. 2000, 917.